Vti1A Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
VTI1A (Vesicular Transport Protein SNARE VTI1A Homolog A) is a SNARE protein involved in intracellular membrane fusion events. It plays critical roles in synaptic vesicle trafficking, autophagy, and endolysosomal pathways. VTI1A is essential for neurotransmitter release and has been implicated in various neurodegenerative diseases.
- Full Name: Vesicular Transport Protein SNARE VTI1A Homolog A
- Gene Symbol: VTI1A
- UniProt ID: Q9Y5R0
- Molecular Weight: ~26 kDa
- Protein Family: SNARE family (Qa-SNARE)
- Structure: Contains an N-terminal Habc domain (three-helix bundle) and a C-terminal SNARE motif
- Topology: Type II membrane protein with N-terminal cytosolic domain
- Post-translational Modifications: Phosphorylation sites regulate SNARE complex assembly
VTI1A functions as a Qa-SNARE in the formation of SNARE complexes:
- Partners with syntaxins (STX1A, STX4), SNAP-25/23, and other VTI1 family members
- Mediates vesicle fusion with target membranes through coiled-coil interactions
- Essential for synaptic vesicle release and recycling
- Forms both homotypic and heterotypic SNARE complexes
- Synaptic Transmission: Facilitates neurotransmitter release at presynaptic terminals
- Autophagy: Involved in autophagosome-lysosome fusion via STX17-SNAP29-VTI1A complex
- Endolysosomal Trafficking: Regulates endosomal and lysosomal fusion events
- Constitutive Secretion: Controls vesicular transport pathways
- Golgi Function: Involved in Golgi maintenance and protein trafficking
- mTORC1 Regulation: VTI1A-mediated autophagy intersects with mTOR signaling
- Calcium Signaling: Synaptic VTI1A function is calcium-dependent
- Rab GTPase Coordination: Works with RAB11, RAB7 for endosomal trafficking
- Brain: High expression in neurons, especially in cortex, hippocampus, and basal ganglia
- Subcellular Localization: Synaptic vesicles, early/recycling endosomes, late endosomes, lysosomes, autophagosomes
- Cellular Distribution: Predominantly neuronal with some astrocytic and microglial expression
- Development: Expression increases during postnatal development correlating with synaptogenesis
- Altered SNARE complex formation in AD brains
- Impairs synaptic vesicle cycling and neurotransmitter release
- Contributes to memory deficits through synaptic dysfunction
- VTI1A-STX1A interactions disrupted by Aβ oligomers
- Autophagy impairment contributes to amyloid accumulation
- Dysregulated endolysosomal function in PD models
- May affect α-synuclein clearance through autophagy pathways
- Mutations in VTI1A associated with PD risk
- Lysosomal dysfunction impairs protein quality control
- Impaired autophagosome-lysosome fusion in motor neurons
- Motor neuron vulnerability due to altered SNARE function
- Protein aggregate clearance deficits
- Dysregulated autophagy contributes to TDP-43 pathology
- Altered synaptic transmission and neuronal hyperexcitability
- Dysregulated exocytosis contributes to seizure activity
- Impaired vesicle recycling affects inhibitory neurotransmission
| Target |
Approach |
Status |
| SNARE Complex |
Small molecule stabilizers |
Preclinical |
| Autophagy Enhancement |
mTOR-independent activation |
Research |
| Gene Therapy |
AAV-VTI1A delivery |
Experimental |
- SNARE Modulators: Developing compounds that stabilize/facilitate SNARE complex formation
- Autophagy Enhancers: Targeting VTI1A to improve lysosomal function
- Gene Therapy: AAV-mediated delivery of functional VTI1A
- Combination Approaches: SNARE modulation + autophagy enhancement
- Knockout Mice: Embryonic lethal (E7.5), severe developmental defects
- Conditional Knockouts: Synaptic transmission defects, impaired autophagy
- Transgenic Models: VTI1A overexpression shows neuroprotection
- ** Zebrafish Models**: Motor and behavioral phenotypes
- Cryo-EM structures of VTI1A-containing SNARE complexes
- In vivo monitoring of VTI1A dynamics using fluorescent tags
- Patient-derived iPSC models with VTI1A variants
- High-throughput screening for VTI1A-targeted therapeutics
The study of Vti1A Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.